Ezequiel Ruiz-Mateos
Overview
Explore the profile of Ezequiel Ruiz-Mateos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
1697
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perez-Castro M, Hernandez-Rasco F, Alonso-Bellido I, Letran-Sanchez M, Perez-Villegas E, Vitalle J, et al.
Int J Mol Sci
. 2025 Jan;
26(2).
PMID: 39859507
The ubiquitin proteasome system (UPS) is implicated in protein homeostasis. One of the proteins involved in this system is HERC1 E3 ubiquitin ligase, which was associated with several processes including...
2.
Gasca-Capote C, Ruiz-Mateos E
Curr Opin HIV AIDS
. 2025 Jan;
20(2):165-171.
PMID: 39773856
Purpose Of Review: To summarize the heterogeneity in the elite controllers population with the aim to identify a compatible profile with a persistent HIV remission, making distinction between persistent elite...
3.
Kared H, Tan C, Narang V, Tan S, Xian C, Wei A, et al.
Sci Rep
. 2024 Dec;
14(1):30779.
PMID: 39730488
Long-term control of viral replication relies on the efficient differentiation of memory T cells into effector T cells during secondary immune responses. Recent findings have identified T cell precursors for...
4.
Trujillo-Rodriguez M, Munoz-Muela E, Serna-Gallego A, Praena-Fernandez J, Perez-Gomez A, Gasca-Capote C, et al.
PLoS One
. 2024 Nov;
19(11):e0314574.
PMID: 39570969
[This corrects the article DOI: 10.1371/journal.pone.0269875.].
5.
Sanchez-Gaona N, Gallego-Cortes A, Astorga-Gamaza A, Rallon N, Benito J, Ruiz-Mateos E, et al.
JCI Insight
. 2024 Sep;
9(20).
PMID: 39288262
Elite controllers (ECs), a unique group of people with HIV (PWH), exhibit remarkable control of viral replication in the absence of antiretroviral therapy. In this study, we comprehensively characterized the...
6.
Poveda E, Fitzgerald W, Alonso-Dominguez J, Aguayo-Arjona J, Marino A, Alvarez H, et al.
Front Immunol
. 2024 Sep;
15:1446730.
PMID: 39267749
Plasma cytokine levels were quantified among 30 persons with HIV (PWH) identified as elite controllers (15 transient controllers [studied a median of 1.38 years before losing viral control] and 15...
7.
Munoz-Muela E, Trujillo-Rodriguez M, Serna-Gallego A, Saborido-Alconchel A, Gasca-Capote C, Alvarez-Rios A, et al.
EBioMedicine
. 2024 Sep;
108:105338.
PMID: 39265504
Background: Among people living with HIV-1 (PHIV), immunological non-responders (INR) experience incomplete immune recovery despite suppressive antiretroviral treatment (ART), facing more severe non-AIDS events than immunological responders (IR) due to...
8.
Mann B, Sanz M, Clohosey M, Langlands K, Chitrakar A, Moreno C, et al.
Res Sq
. 2024 Aug;
PMID: 39149467
Curative strategies for human immunodeficiency virus (HIV-1) infection are hindered by incomplete characterization of the latent reservoir and limited enhancement of anti-HIV immune responses. In this study, we identified a...
9.
Jimenez-Leon M, Gasca-Capote C, Roca-Oporto C, Espinosa N, Sobrino S, Fontillon-Alberdi M, et al.
JCI Insight
. 2024 Jul;
9(16).
PMID: 38980725
BACKGROUNDWe evaluated the safety and viral rebound, after analytical treatment interruption (ATI), of vedolizumab and ART in recent HIV-1 infection. We used this model to analyze the effect of α4β7...
10.
Lebron J, Ostos F, Martinez-Santa M, Garcia-Moscoso F, Lopez-Lopez M, Moya M, et al.
J Mater Chem B
. 2024 May;
12(21):5220-5237.
PMID: 38695162
The HIV attacks the immune system provoking an infection that is considered a global health challenge. Despite antiretroviral treatments being effective in reducing the plasma viral load in the blood...